Ordinary Shares

Ordinary Shares

Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.

The securities are held by Cream Capital Limited ("Cream"). Mr. Griffiths is a director and the controlling shareholder of Cream. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.


Shares acquired pursuant to a compensation plan for non-employee directors.


This Form 4 is jointly filed by Nathaniel Bradley ("Mr. Bradley") and EOS Technology Holdings Inc. ("EOS"). The shares of common stock, par value $0.0001 per share (the "Common Stock") of the issuer are beneficially owned both directly and indirectly, as outlined above and more fully described below, by Mr. Bradley. 300,000 shares of Common Stock of the issuer were transferred by EOS to a third party in connection with that certain Settlement Agreement and Release of all Claims, dated as of July 30, 2025, by and between the issuer, Mr. Bradley, and various other parties.

An aggregate of 300,000 shares of Common Stock of the issuer were transferred by EOS to two separate third parties in connection with one Settlement Agreement and Release, dated as of July 31, 2025, by and between EOS, Mr. Bradley, and one of the third parties receiving shares of Common Stock.

Mr. Bradley, as an officer and member of the board of directors of EOS, has the power to dispose of and the power to vote the shares of Common Stock beneficially owned by EOS. Mr. Bradley disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act") or for any other purposes.

Mr. Bradley disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 of the Exchange Act or for any other purposes.


Common Stock

Restricted stock units issued in connection with the Reporting Person's appointment as Co-Chief Executive Officer and corresponding employment agreement entered into on July 24, 2025 by and between the Reporting Person and the Issuer.

Each restricted stock unit represents a contingent right to receive one share of SharpLink Gaming, Inc common stock.

The restricted stock units shall vest with one-third (1/3) on the first (1st) anniversary of July 24, 2025, and the remaining units vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued employment with the Issuer as of the vesting date.

Note: 1. On July 24, 2025, the reporting person was also granted performance-based restricted stock units that are subject to material conditions beyond the reporting person's control, and, therefore, are not considered derivative securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, and are excluded from this report.
2. For purposes of Footnote 6 to this Form 4, the grant date, or July 24, 2025, for such restricted stock unit awards means the date that the Company established the vesting terms and the number of shares subject to the grant under the employment agreement; however the Compensation Committee has 30 days to formally approve the grant and register the shares.


Debra Tate Johnson, by Power of Attorney


Common Stock

Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs vested in full on July 31, 2025.

Includes (i) 122 shares of Common Stock, (ii) 5,000 RSUs, which were granted to the Reporting Person on July 31, 2025 as reported herein, and (iii) 5,000 shares of Common Stock, which the Reporting Person has the right to acquire upon the exercise of stock options exercisable within 60 days of July 31, 2025.

The exercise price of the Options (as defined below) was determined based on the closing price of the Common Stock on the date the Options were conditionally approved by the board of directors.

Reflects a grant of stock options (the "Options") made to the Reporting Person under the Plan. The Options were approved by the board of directors on April 28, 2025, subject to stockholder approval of an increase in the number of shares available for issuance under the Plan under which the Options were granted (the "Plan Amendment"). The Plan Amendment was approved by stockholders on July 31, 2025. The Options vested in full and became immediately exercisable on July 31, 2025.

/s/ Brian Schaffner, Attorney-in-Fact for Tien Q. Nguyen


Common Stock

Includes (i) 122 shares of Common Stock, (ii) 5,000 RSUs, which were granted to the Reporting Person on July 31, 2025 as reported herein, and (iii) 5,400 shares of Common Stock, which the Reporting Person has the right to acquire upon the exercise of stock options exercisable within 60 days of July 31, 2025.

/s/ Brian Schaffner, Attorney-in-Fact for Steve Shum


Common Stock

The exercise price of the Options (as defined below) was determined based on the closing price of the Issuer's common stock, par value $0.001 per share, on the date the Options were conditionally approved by the compensation committee of the board of directors.

Reflects a grant of stock options (the "Options") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "Plan"). The Options were approved by the compensation committee of the board of directors on April 9, 2025, subject to stockholder approval of an increase in the number of shares available for issuance under the Plan under which the Options were granted (the "Plan Amendment"). The Plan Amendment was approved by stockholders on July 31, 2025. The Options vested in full and became immediately exercisable on July 31, 2025.

/s/ Brian Schaffner, Attorney-in-Fact for Paul Thomas Shoun


Common Stock

Includes (i) 122 shares of Common Stock, (ii) 5,000 RSUs, which were granted to the Reporting Person on July 31, 2025 as reported herein, and (iii) 5,300 shares of Common Stock, which the Reporting Person has the right to acquire upon the exercise of stock options exercisable within 60 days of July 31, 2025.

/s/ Brian Schaffner, Attorney-in-Fact for George Lefevre


Common Stock

/s/ Brian Schaffner, Attorney-in-Fact for Carson E. Heagen


Common Stock


Common Stock

The shares were acquired from the issuer's treasury in satisfaction of outstanding liabilities, debt financing, accrued interest, and bonuses in lieu of cash, at a deemed fair market value of $1.31 per share (based on the average closing price over the prior 60 trading days).

Following the acquisition of 4,685,029 shares, based on 571,059 shares held prior to the transaction (per the April 15, 2025, Form 10-K footnote).

The gift disposition was made with no consideration received.

Amount held following the gift disposition of 878,074 shares.

The Series A Preferred Stock is convertible into shares of Common Stock at any time, at a conversion rate of 111.11 shares of Common Stock per share of Series A Preferred Stock. The Series A Preferred Stock has no expiration date. The Reporting Person returned the shares for cancellation with no consideration received.

This Form 4/A amends the Form 4 filed on 01/26/2024 to report additional transactions on 05/28/2025, 06/02/2025, and 06/30/2025. The Reporting Person's beneficial ownership also includes 227,003 shares issuable upon exercise of Series A Warrants ($90.00 per share, exercisable immediately, expiring 08/11/2025), 56,751 shares issuable upon exercise of Series B Warrants ($45.00 per share, exercisable immediately, expiring 08/11/2025), and 20,000 shares issuable upon exercise of vested employee stock options ($0.03 per share, vesting in three equal annual installments beginning on the one-year anniversary of the grant date, expiring three years after each vesting date).


Common Stock

Common Stock

The restricted stock unit grant was approved on July 31, 2025 and vests in four equal installments on January 31, 2026, July 31, 2026, January 31, 2027 and July 31, 2027.

Represents the conversion upon vesting of restricted stock units into common stock on August 1, 2025. These restricted stock units and the shares of common stock issued upon vesting of such units were acquired under the Company's Amended and Restated Equity Incentive Plan, without payment by the reporting person.

/s/ Norman Roth Attorney-In-Fact for Cameron Munter


Common Stock

Common Stock

/s/ Norman Roth Attorney-In-Fact for John Daly


Common Stock

Common Stock

/s/ Norman Roth Attorney-In-Fact for Lawrence S. Sharnak


Common Stock

Common Stock

/s/ Norman Roth Attorney-In-Fact for Bill Korn


Common Stock

Common Stock

/s/ Norman Roth Attorney-In-Fact for Anne Busquet


The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.10 to $13.11, inclusive. The Reporting Person undertakes to provide Saga Communications, Inc., any security holder of Saga Communications, Inc.,
or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.05 to $13.07, inclusive. The Reporting Person undertakes to provide Saga Communications, Inc., any security holder of Saga Communications, Inc.,
or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.


Hoops Elliot Dean

1700 S. PAVILION CENTER DRIVE, SUITE 800

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.54 to $60.51. The reporting person undertakes to provide to MP Materials Corp., any security holder of MP Materials Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.53 to $61.26. The reporting person undertakes to provide to MP Materials Corp., any security holder of MP Materials Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.61 to $61.64. The reporting person undertakes to provide to MP Materials Corp., any security holder of MP Materials Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.


Reflects tax withholding on August 1, 2025 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on August 1, 2021.


Reflects an award of restricted stock units with respect to Common Shares ("RSUs"), with a vesting commencement date of March 31, 2025, which service-vest (i) 20% on the first anniversary of the vesting commencement date and (ii) in 16 successive equal quarterly installments thereafter, subject to the reporting person's continuous service through each vesting date.

Reflects an award of performance restricted stock units with respect to Common Shares ("PSUs") across six share price hurdle tranches, as follows: $15.00 (14.71% of PSUs); $17.50 (7.35% of PSUs); $20.00 (8.82% of PSUs); $22.50 (11.77% of PSUs); $25.00 (22.06% of PSUs); and $30.00 (35.29% of PSUs). The PSUs will vest tranche-by-tranche on the first date that both the performance condition and the service condition with respect to the applicable tranche of the PSUs has been satisfied. The performance condition will be deemed satisfied for each tranche of PSUs on the first date, during the performance period ending on July 26, 2029, when the Company's trailing 30-day volume weighted average trading price per share for trading days during the performance period exceeds the share price hurdle applicable to such tranche (as specified above). (Continued in footnote 3)

(Continued from footnote 2) The service condition will be deemed satisfied for each tranche of PSUs on the first anniversary of the date on which the performance condition is first satisfied with respect to such tranche, subject to the reporting person's continuous service through such anniversary. In addition, following the satisfaction of the performance condition and service condition and the vesting of any tranche of the PSUs, the common shares underlying the applicable vested tranche of PSUs are subject to a further two-year holding period before such common shares may be sold.

By: /s/ Jo Chen, as Attorney-in-Fact for Frank Torti


Reflects an award of restricted stock units with respect to Common Shares ("RSUs"), with a vesting commencement date of May 20, 2025, which service-vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in 12 successive equal quarterly installments thereafter, subject to the reporting person's continuous service through each vesting date.

By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker


Common Stock

Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements and payment by the Reporting Person of the option exercise price. This is not an open market sale of securities. This option was automatically exercised on the expiration date.

Includes, as of the transaction date (i) 77,784 unvested RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 144,240 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 15,000 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;

(continued from footnote 2) (iv) 47,500 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (v) 10,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vi) 194,166 shares of common stock directly owned by the reporting person, which includes the option exercise described in footnote 1 and prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

The option was granted on July 30, 2015 and is fully vested.

/s/ Kaitlin M. Kestenberg-Messina, by Michael A. Goldstein as Attorney-in-fact


KRATOS DEFENSE & SECURITY SOLUTIONS, INC.

This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 22, 2024.

The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $54.56 to $55.50 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $55.555 to $56.26 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

Includes 1,723 shares purchased through Issuer's Employee Stock Purchase Plan and approximately 6,725 shares held through Issuer's 401(k) Plan.

Stacey G. Rock, by Eva Yee, Attorney-In-Fact


Common Stock, par value $0.01 per share

Common Stock, par value $0.01 per share

The shares were sold in multiple transactions at prices ranging from $372.22 to $373.00. The price reported above reflects the weighted-average price. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Includes 87 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan on June 26, 2025.

The exercise price of this stock option was originally $129.11 per share but was reduced to $125.11 per share to reflect the impact of special dividends paid to our stockholders.

On March 3, 2021, the Reporting Person was granted an option to purchase 1,453 shares of common stock pursuant to the Wingstop Inc. 2015 Omnibus Incentive Compensation Plan ("the Plan"). The option vests and becomes exercisable in three equal annual installments beginning on the first anniversary of the date of grant.

The exercise price of this stock option was originally $144.94 per share but was reduced to $140.94 per share to reflect the impact of special dividends paid to our stockholders.

On March 22, 2022, the Reporting Person was granted an option to purchase 2,157 shares of common stock pursuant to the Plan. The option vests and becomes exercisable in three equal annual installments beginning on the first anniversary of the date of grant.

/s/ Albert G. McGrath by Power of Attorney


Common Stock, par value $0.01 per share

The shares were sold in multiple transactions at prices ranging from $376.129 to $376.418. The price reported above reflects the weighted-average price. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

On March 2, 2022, the Reporting Person was granted an option to purchase 2,157 shares of common stock pursuant to the Wingstop Inc. 2015 Omnibus Incentive Compensation Plan. The option vests and becomes exercisable in three equal annual installments beginning on the first anniversary of the date of grant.


The shares were sold in multiple transactions at prices ranging from $369.8686 to $370.4262. The price reported above reflects the weighted-average price. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.


Class A Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock of the Issuer.

On January 23, 2024, the Reporting Person was granted 193,115 RSUs, one half of which vested on December 31, 2024. The remaining portion of the RSUs vest in five substantially equal monthly installments on the last day of the month through December 31, 2025. These RSUs are subject to potential acceleration or forfeiture in accordance with the terms of that certain Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement, dated as of January 22, 2024, between the Issuer and the Reporting Person.


The transaction represents the number of shares of Class A Common Stock withheld by the Issuer to satisfy tax withholding liabilities in connection with the net settlement of restricted stock units.


These securities are held by APM33, LLC, of which the Reporting Person is a manager.


The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Exchange Act in connection with the Issuer's initial public offering ("IPO"), and the transaction is reported herein pursuant to Rule 16a-2(a).

On June 2, 2025, the Reporting Person transferred as gifts, for no consideration, shares of the Issuer's Class A Common Stock to three separate trusts for the benefit of certain family members. The Reporting Person disclaims beneficial ownership and has no pecuniary interest in the securities transferred to such trusts. These pre-IPO transactions represent a reduction in the Reporting Person's beneficial ownership of the Issuer's Class A Common Stock.

Includes 1,788,188 restricted stock units ("RSUs") that vest in accordance with the terms of the applicable awards. Each RSU represents a contingent right to receive one share of Class A Common Stock.

Represents an award of RSUs that was acquired through an exempt transaction with the Issuer.

Includes 7,208,329 RSUs that vest in accordance with the terms of the applicable awards. Each RSU represents a contingent right to receive one share of Class A Common Stock.

The transaction represents the number of shares of Class A Common Stock withheld by the Issuer to satisfy tax withholding liabilities in connection with the net settlement of RSUs.


Class B Common Stock

Class B Common Stock

Class B Common Stock

Class A Common Stock

Class B Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement

This RSU represents an equity security previously reported on the Reporting Person's Form 3, which was acquired through an exempt transaction with the Issuer. The grant of this RSU occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Exchange Act in connection with the Issuer's initial public offering ("IPO"), and the transaction is reported herein pursuant to Rule 16a-2(a).

The award vests as to (i) 10% of the total award on the first anniversary of July 1, 2025, (ii) 20% of the total award on each of the second, third, and fourth anniversaries of July 1, 2025, and (iii) 30% of the total award on the fifth anniversary of July 1, 2025, so long as the Reporting Person is in continuous service through each applicable vesting date as the Issuer's Chief Executive Officer or in certain other eligible positions as reasonably determined by the Compensation Committee in its good faith discretion.

These RSUs do not expire; they either vest or are cancelled prior to the vesting date.

The award is subject to certain service-based and stock price-based vesting conditions, with the stock price-based vesting condition comprised of seven tranches that are eligible to vest based on the achievement of certain specified stock price targets. The performance period for each tranche begins on the Issuer's IPO and ends on the earlier of (i) the tenth anniversary of the Issuer's IPO or (ii) the occurrence of a change in control (as defined in the agreement governing the award). As to any portion of the award that satisfies the stock price-based vesting condition, the service-based vesting condition will be satisfied in seven substantially equal installments on each of the first seven anniversaries of July 1, 2025, so long as the Reporting Person is in continuous service through each applicable vesting date as the Issuer's Chief Executive Officer or in certain other eligible positions as reasonably determined by the Compensation Committee in its good faith discretion.

The stock option exercise occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Exchange Act in connection with the Issuer's IPO, and the transaction is reported herein pursuant to Rule 16a-2(a).

The options are fully vested.

The award will expire upon the earlier of (a) August 21, 2029 and (b) the date that is one year following the Issuer's IPO.

Each share of Class B Common Stock is convertible into one share of the lssuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions
described in the Issuer's Amended and Restated Certificate of Incorporation.

The issuance of shares of Class B Common Stock upon the exercise of stock options occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Exchange Act in connection with the Issuer's IPO, and the transaction is reported herein pursuant to Rule 16a-2(a).

The award was granted subject to a performance-based vesting condition that was satisfied in connection with the Issuer's IPO, as well as a service-based vesting schedule. The original award, representing 11,250,000 RSUs, vested as to 10% of the total award on July 1, 2022, 20% of the total award on July 1, 2023, 30% of the total award on July 1, 2024, and 40% of the total award on July 1, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date.
In May 2024, the Board of Directors modified the award to remove the performance-based vesting condition with respect to 3,375,000 RSUs for which the service-based vesting condition had been met as of the modification date, resulting in the settlement of such RSUs
into shares of Class B common stock.

The transaction represents the number of shares of Class B Common Stock withheld by the Issuer to satisfy tax withholding liabilities in connection with the net settlement of RSUs.

These shares are held by the Dylan Field 2024 Annuity Trust, of which the Reporting Person is trustee.

These shares are held by the Field 2021 Descendants Trust, of which Bryn Mawr Trust Company of Delaware serves as trustee and may be replaced at the discretion of the Reporting Person.

These shares are held of record by LLL Investments LLC which is associated with the Reporting Person.


Common stock, $0.001 par value per share

Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, $0.001 par value per share.

One-third (1/3rd) of the restricted stock units shall vest upon each of the first three anniversaries of August 1, 2025, subject to the Reporting Person's continued employment or service with the Issuer through each such date.


The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Exchange Act in connection with the Issuer's initial public offering, and the transaction is reported herein pursuant to Rule 16a-2(a).

Represents a restricted stock unit award that was acquired through an exempt transaction with the Issuer.


Represents a restricted stock unit award that was acquired through an exempt transaction with the Issuer


Concurrent with the consummation of the secondary offering by TCFIII Spaceco SPV LP of the Issuer's Common Stock, as previously reported by the Issuer on Form 8-K dated July 23, 2025 (the "Secondary Offering"), TCFIII Spaceco SPV LP effected a distribution in-kind consisting of all shares of Common Stock held by TCFIII Spaceco SPV LP not sold in the Secondary Offering (the "Trive LP Distribution") to Trive Capital Fund III LP ("Trive Fund III") and Trive Capital Fund III-A LP ("Trive Fund III-A") and Trive Fund III and Trive Fund III-A effected a pro rata distribution-in-kind of such shares of Common Stock to its partners for no consideration.  In the distribution in-kind, the Reporting Person received 54,796 shares of Common Stock for no consideration.


Class A Common Stock

No shares of Class A Common Stock were transferred or sold upon the vesting of the restricted stock units ("RSUs") other than to the Issuer to satisfy withholding taxes. The Reporting Person received the net of the 4,310 shares of Class A Common Stock underlying the RSUs listed in Table II, and 2,084 shares of Class A Common Stock withheld by the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

On May 1, 2024, the Reporting Person was granted 68,963 RSUs vesting quarterly over four (4) years from May 1, 2024.


Concurrent with the consummation of the secondary offering by TCFIII Spaceco SPV LP of the Issuer's Common Stock, as previously reported by the Issuer on Form 8-K dated July 23, 2025 (the "Secondary Offering"), TCFIII Spaceco SPV LP effected a distribution in-kind consisting of all shares of Common Stock held by TCFIII Spaceco SPV LP not sold in the Secondary Offering (the "Trive LP Distribution") to Trive Capital Fund III LP ("Trive Fund III") and Trive Capital Fund III-A LP ("Trive Fund III-A") and Trive Fund III and Trive Fund III-A effected a pro rata distribution-in-kind of such shares of Common Stock to its partners for no consideration.  In the distribution in-kind, the Reporting Person received 3,501,433 shares of Common Stock for no consideration.


Class A Common Stock

No shares of Class A Common Stock were transferred or sold upon the vesting of the restricted stock units ("RSUs") other than to the Issuer to satisfy withholding taxes. The Reporting Person received the net of the 808 shares of Class A Common Stock underlying the RSUs listed in Table II, and 354 shares of Class A Common Stock withheld by the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

On February 10, 2025, the Reporting Person was granted 9,692 RSUs vesting monthly over one (1) year from March 1, 2025.


Represents the weighted average price of shares sold at prices that ranged from $68.5100 to $69.4400.

Represents the weighted average price of shares sold at prices that ranged from $69.5700 to $69.9100.

The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted on March 7, 2025.


Represents restricted stock units (each, an "RSU" and collectively, "RSUs") granted on July 30, 2025, pursuant to the Issuer's 2025 Short-Term Incentive Plan (the "STIP") and under its 2022 Equity Incentive Plan (as amended, the "Plan") upon achievement of performance goals for the fiscal quarter ended June 30, 2025, as approved by the Compensation Committee. Each RSU represents a contingent right to receive one share of common stock of the Issuer. 50% of these RSUs will vest on the date that is 12 months from the date of grant and the remaining 50% will vest in four equal quarterly installments over the next 12-month period thereafter, subject to the continuous service of the reporting person on such vesting dates and compliance with the terms and conditions of the STIP and the Plan. The number of RSUs awarded is based on the closing price of the Issuer's common stock as reported on the Nasdaq Capital Market on July  30, 2025 of $0.4019.

Due to a character limit, Footnote 2 is a continuation of Footnote 1: Unvested RSUs are forfeited if the reporting person is separated from service with the Issuer for any or no reason.

Represents RSUs granted on July 30, 2025, by the Compensation Committee under the Plan as compensation for services as an executive officer during the fiscal quarter ended June 30, 2025. Each RSU represents a contingent right to receive one share of common stock of the Issuer. 50% of these RSUs will vest on the date that is 12 months from the date of grant and the remaining 50% will vest in four equal quarterly installments over the next 12-month period thereafter, subject to the continuous service of the reporting person on such vesting dates and compliance with the terms and conditions of the Plan. The number of RSUs awarded is based on the closing price of the Issuer's common stock as reported on the Nasdaq Capital Market on July 30, 2025 of $0.4019. Unvested RSUs are forfeited if the reporting person is separated from service with the Issuer for any or no reason.

The reporting person is the managing member of Giri Devanur Holdings LLC and holds sole voting and investment power with respect to those shares of common stock.


Acquisition is in connection with the September 6, 2022 award and achievement of performance objectives.

Represents the number of shares withheld by the Issuer upon the vesting of restricted shares to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Stride common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Stride common stock on the most recent prior market day.


Knight-Swift Transportation Holdings Inc.

Class A Common Stock

Restricted units convert to Class A Common Stock on a one-for-one basis.

The restricted stock unit grant vests in five equal installments beginning on July 31, 2022.  Stock is issued when and as vested.


Represents shares held directly by ARCH Venture Fund X, L.P. ("ARCH X"). ARCH Venture Partners X, L.P. ("AVP X LP") is the sole general partner of ARCH X.

Represents shares held directly by ARCH Venture Fund X Overage, L.P. ("ARCH X Overage"). ARCH Venture Partners X Overage, L.P. ("AVP X Overage LP") is the sole general partner of ARCH X Overage.

ARCH Venture Partners X, LLC ("AVP X LLC") is the sole general partner of each of AVP X LP and AVP X Overage LP. In addition to the Reporting Person, Keith Crandell, Kristina Burow and Steve Gillis are also members of the investment committee of AVP X LLC (the "AVP X Investment Committee Members").  AVP X LP and AVP X Overage LP  may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, respectively, AVP X LLC may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, and each of the AVP X Investment Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X and ARCH X Overage.  AVP X LP, AVP X Overage LP, AVP X LLC, and the other AVP X Investment Committee Members have filed a separate Form 4 and disclaim beneficial ownership except to the extent of any pecuniary interest therein.

The Reporting Person is also an AVP X Investment Committee Member and may be deemed to share the power to direct the disposition and vote of own the shares held by ARCH X and ARCH X Overage.  The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

Represents shares held directly by ARCH Venture Fund XII, L.P. ("ARCH XII"). ARCH Venture Partners XII, L.P. ("AVP XII LP") is the general partner of ARCH XII. ARCH Venture Partners XII, LLC (AVP XII LLC) is the general partner of AVP XII LP.  In addition to the Reporting Person, Keith Crandell, Kristina Burow and Steven Gillis are also members of the investment committee of AVP XII LLC (the "AVP XII LLC Investment Committee Members"). Each of AVP XII LP and AVP XII LLC may be deemed to beneficially own the shares held by ARCH XII, and each of the AVP XII LLC Investment Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH XII. Each of AVP XII LP, AVP XII LLC and the other AVP XII LLC Investment Committee Members have filed a separate Form 4 and disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any.

The Reporting Person is also an AVP XII Investment Committee Member and may be deemed to to share the power to direct the disposition and vote of the shares held by ARCH XII.  The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

Shares held by a trust for the benefit of family members of the Reporting Person.

Robert Nelsen /s/ Mark McDonnell, attorney-in-fact


Class A Common Stock

Restricted stock units convert to Class A Common Stock on a one-for-one basis.

The restricted stock unit grant vests in five equal installments beginning July 31, 2022.  Stock is issued when and as vested.


ARCH Venture Partners X, LLC ("AVP X LLC") is the sole general partner of each of AVP X LP and AVP X Overage LP. Keith Crandell, Kristina Burow and Steven Gillis are members of the investment committee of AVP X LLC (the "AVP X Committee Members"). AVP X LP and AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, respectively, AVP X LLC may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X and ARCH X Overage. AVP X LP, AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by them for Section 16 or any other purpose.

Represents shares held directly by ARCH Venture Fund XII, L.P. ("ARCH XII"). ARCH Venture Partners XII, L.P. ("AVP XII LP") is the general partner of ARCH XII. ARCH Venture Partners XII, LLC ("AVP XII LLC") is the general partner of AVP XII LP.  Keith Crandell, Kristina Burow and Steven Gillis are members of the investment committee of AVP XII LLC (the "AVP XII LLC Committee Members"). Each of AVP XII LP and AVP XII LLC may be deemed to beneficially own the shares held by ARCH XII, and each of the AVP XII LLC Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH XII. Each of AVP XII LP, AVP XII LLC and the AVP XII LLC Committee Members disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any.

This Form 4 is one of two reports relating to the same transaction being filed jointly by ARCH X, AVP X LP, ARCH X Overage, AVP X Overage LP, AVP X LLC, ARCH XII, AVP XII LP, AVP XII LLC, Keith Crandell, Kristina Burow and Steven Gillis (collectively, the "Reporting Persons"). Robert Nelsen has direct ownership of Common Stock and is filing his own Form 4 separately.


Common Stock

Common Stock

Common Stock

These options are currently vested.

Options previously reported as indirectly owned through a grantor retained annuity trust of which the reporting person is beneficiary were transferred to the reporting person directly. This transaction represents a change in the form of ownership from indirect to direct, with no change in the reporting person's pecuniary interest in the securities.

/s/ Gregory R. Packer, as Attorney-in-Fact


The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.910 to $3.935. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.100 to $4.135. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Dr. Leff does not own these shares in his individual capacity. These shares are owned directly by Luminari Capital, L.P. ("Luminari Capital"). The general partner of Luminari Capital is Luminari Capital Partners, LLC. Edgar Bronfman has an assignee interest in Luminari Capital Partners, LLC. Dr. Leff, as managing member of Luminari Capital Partners, LLC, may be deemed to have shared voting and investment power with respect to these securities. Each of Dr. Leff, Mr. Bronfman and Luminari Capital Partners, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein and the inclusion of these securities in this filing shall not be deemed an admission by any of them of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

Dr. Leff does not own these shares in his individual capacity. These shares are owned directly by Waverley Capital LP ("Waverley Capital"). The general partner of Waverley Capital is Waverley Capital Partners, LLC. Dr. Leff and Mr. Bronfman, as managing members of Waverley Capital Partners, LLC, may be deemed to have shared voting and investment power with respect to these securities. Each of Dr. Leff, Mr. Bronfman and Waverley Capital Partners, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein and the inclusion of these securities in this filing shall not be deemed an admission by any of them of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

Dr. Leff does not own these shares in his individual capacity. These shares are owned directly by WL fuboTV, LP ("WL fuboTV"). The general partner of WL fuboTV is WL fuboTV GP, LLC. Dr. Leff and Mr. Bronfman, as managing members of WL fuboTV GP, LLC, may be deemed to have shared voting and investment power with respect to these shares. Each of Dr. Leff, Mr. Bronfman and WL fuboTV GP, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein and the inclusion of these securities in this filing shall not be deemed an admission by any of them of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.


The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.250 to $4.265. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Held by HillCour Investment Fund, LLC, of which Mr. Lamendola is the Manager, and holds the voting and dispositive power over the securities held by HillCour Investment Fund, LLC.

Held by WellEnterprises USA, LLC, a wholly owned subsidiary of HillCour, Inc., which is wholly owned by HillCour Holding Corporation, a corporation controlled by Mr. Lamendola. Mr. Lamendola holds the voting and dispositive power over the securities held by WellEnterprises USA, LLC.


Common Stock

Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

Reflects a grant of RSUs to Reporting Person, a director of the Issuer, which will vest at the earlier of (i) the next annual shareholder meeting of the Issuer after July 14, 2025 (the "Vesting
Commencement Date") or (ii) the 12 month anniversary of the Vesting Commencement Date.


Common Stock


8,016,933 of the total reported securities are owned as of July 30, 2025 by the following subsidiary of Berkshire Hathaway Inc. ("Berkshire"): Government Employees Insurance Company (8,016,933). As Berkshire is in the chain of ownership of the subsidiary, it may be deemed presently to both beneficially own and have a pecuniary interest in all shares presently directly owned by the subsidiary. Warren E. Buffett, as the controlling stockholder of Berkshire, may be deemed presently to beneficially own, but only to the extent he has a pecuniary interest in, the shares presently owned by the subsidiary. Mr. Buffett disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

972,947 of the total reported securities are owned as of July 30, 2025 by the following pension plans of Berkshire's subsidiaries: Precision CastParts Corp Master Trust (362,815), Scott Fetzer Collective Investment Trust (95,100) and BNSF Master Retirement Trust (515,032). Each of Berkshire, Mr. Buffett and these pension plans disclaims beneficial ownership in such shares.

/s/ Warren E. Buffett, on behalf of himself and each other reporting person hereunder


Common Stock, par value $.0001 per share

Pursuant to the Agreement and Plan of Merger, dated as of May 3, 2024, by and between Uniti Group Inc. ("Old Uniti") and Windstream Holdings II, LLC, as amended by Amendment No. 1 to the Agreement and Plan of Merger, dated as of July 17, 2024 (the "Merger Agreement"), the shares of Common Stock reported above were issued to the Elliott Funds (as defined below) in exchange for [10,120,963] shares of Old Uniti common stock.

This Form 4 is being filed by Elliott Investment Management L.P., a Delaware limited partnership ("EIM" or the "Reporting Person"), which serves as the investment manager of Elliott Associates, L.P., a Delaware limited partnership ("Elliott") and Elliott International, L.P., a Cayman Islands limited partnership ("Elliott International", and together with Elliott and their respective subsidiaries, the "Elliott Funds"), with respect to the securities held by the Elliott Funds. Elliott Investment Management GP LLC, a Delaware limited liability company ("EIM GP"), is the sole general partner of EIM. Paul E. Singer is the sole managing member of EIM GP. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any.

Elliott Investment Management L.P., /s/ Elliot Greenberg, Vice President


Common Stock, par value $0.001 per share

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.01 to $55.24, inclusive. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer, or a shareholder of the Issuer full information regarding the number of shares sold at each separate price.

/s/ Dov Gottlieb, as attorney-in-fact for Guy Melamed


The sale of shares was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person for the benefit of the reporting person's relatives on December 13, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.00 to $122.975, inclusive. The reporting person undertakes to provide Arista Networks, Inc., any security holder of Arista Networks, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These shares are held in trust for the benefit of the children of the reporting person for which the reporting person serves as trustee. The reporting person shares voting and investment control over the shares but disclaims beneficial ownership of the shares.

The exercises and/or sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2024.

These shares are held by a family trust for which the reporting person is co-trustee.

These shares are held in trust for the benefit of relatives of the reporting person for which the reporting person serves as co-trustee.  The reporting person shares voting and investment control over the shares but disclaims beneficial ownership of the shares.

By: Isabelle Bertin-Bailly, Attorney-in-Fact For: Jayshree Ullal


Shares received upon the vesting of performance share units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors (the "Committee") pursuant to the 2018 Omnibus Incentive Plan.  These performance share units were granted by the Committee in August 2022.  The number of shares of common stock received upon the vesting of these performance share units was determined based upon the Company's performance with regard to pre-established financial performance metrics for the performance period from fiscal 2023 to fiscal 2025.

These shares were withheld upon the vesting of performance share units to pay tax withholding obligations.


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025.

This transaction was executed in multiple trades during the day at prices ranging from $191.38 to $192.31. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Shares are held by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.

This transaction was executed in multiple trades during the day at prices ranging from $193.56 to $194.54. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $192.55 to $193.50. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $195.57 to $196.45. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $194.57 to $195.56. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

/s/ Veena Bhatia, Attorney-in-Fact for Cannon-Brookes Michael


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 12, 2025.

Shares are held by Farquhar Investment Partnership No. 2.

/s/ Veena Bhatia, Attorney-in-Fact for Farquhar Scott


Represents restricted stock units (each, an "RSU" and collectively, "RSUs") granted on July 30, 2025, pursuant to the Issuer's 2025 Short-Term Incentive Plan (the "STIP") and under its 2022 Equity Incentive Plan (as amended, the "Plan") upon achievement of performance goals for the fiscal quarter ended June 30, 2025, as approved by the Compensation Committee. Each RSU represents a contingent right to receive one share of common stock of the Issuer. 50% of these RSUs will vest on the date that is 12 months from the date of grant and the remaining 50% will vest in four equal quarterly installments over the next 12-month period thereafter, subject to the continuous service of the reporting person on such vesting dates and compliance with the terms and conditions of the STIP and the Plan. The number of RSUs awarded is based on the closing price of the Issuer's common stock as reported on the Nasdaq Capital Market on July  30, 2025 of $0.4019.

Due to a character limit, Footnote 2 is a continuation of Footnote 1: Unvested RSUs are forfeited if the reporting person is separated from service with the Issuer for any or no reason.

Represents RSUs granted on July 30, 2025, by the Compensation Committee under the Plan as compensation for services as an executive officer during the fiscal quarter ended June 30, 2025. Each RSU represents a contingent right to receive one share of common stock of the Issuer. 50% of these RSUs will vest on the date that is 12 months from the date of grant and the remaining 50% will vest in four equal quarterly installments over the next 12-month period thereafter, subject to the continuous service of the reporting person on such vesting dates and compliance with the terms and conditions of the Plan. The number of RSUs awarded is based on the closing price of the Issuer's common stock as reported on the Nasdaq Capital Market on July 30, 2025 of $0.4019. Unvested RSUs are forfeited if the reporting person is separated from service with the Issuer for any or no reason.


The transactions were executed pursuant to a Rule 10b5-1 plan.

This transaction was executed in multiple trades at prices ranging from $42.50 to $43.23.  The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

This transaction was executed in multiple trades at prices ranging from $43.74 to $43.77. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

/s/ Jeffrey J. LaValle, under Power of Attorney  for Timothy J. Jahnke


Common Stock

This transaction was executed in multiple trades at prices ranging from $42.42 to $43.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

Based on information from the trustee of the 401(k) Plan.

Option fully vested.

/s/ Jeffrey J. LaValle under Power of Attorney for Mark W. Peterson


Common Stock

Common Stock

Common Stock

Common Stock

Includes shares acquired under the Company's Employee Stock Purchase Plan in 2025.

This transaction was executed in multiple trades at prices ranging from $43.00 to $43.99.  The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

This transaction was executed in multiple trades at prices ranging from $44.00 to $44.21.  The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

This transaction was executed in multiple trades at prices ranging from $43.07 to $43.36.  The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

Option fully vested.

/s/ Jeffrey J. LaValle under Power of Attorney for Sudhanshu Chhabra


Common Stock

Common Stock

Common Stock

Common Stock

This transaction was executed in multiple trades at prices ranging from $42.44 to $43.39.  The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

Option fully vested.

/s/ Jeffrey J. LaValle under Power of Attorney for Michael Troutman


Represents the weighted average sale price for the entire number of shares sold.  The actual sale prices range between $116.585 and $117.58.  Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

Represents the weighted average sale price for the entire number of shares sold.  The actual sale prices range between $117.615 and $118.14.  Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.


These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.

The shares are held by Ice Vulcan Holding Limited. IceVulcan Investments Ltd. is the sole shareholder of Ice Vulcan Holding Limited, and Mr. Dines is the sole shareholder of IceVulcan Investments Ltd. Mr. Dines retains sole voting and investment power with respect to the shares of Class A Common Stock and Class B Common Stock held by Ice Vulcan Holding Limited.


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Restricted stock issued from Seacoast's 2021 Incentive Plan for service as a Director in 2025, and deferred into director's account in Seacoast's Directors Deferred Compensation Plan

Held in Seacoast's Non-employee Directors Deferred Compensation Plan

Granted pursuant to Seacoast Banking Corporation of Florida's 2021 Incentive Plan

Granted pursuant to Seacoast Banking Corporation of Florida's 2013 Incentive Plan

/s/ Kathy L. Hsu as Power of Attorney for Jacqueline L. Bradley


Held in family limited liability company

Common Stock

Held in IRA

Held jointly with spouse

Held jointly with son

Held jointly with daughter

/s/ Kathy L. Hsu as Power of Attorney for H. Gilbert Culbreth, Jr.


Common Stock

Common Stock

Common Stock

Common Stock

Held jointly with spouse

/s/ Kathy L. Hsu as Power of Attorney for Christopher E. Fogal


Common Stock

Common Stock

Held in revocable trust

/s/ Kathy L. Hsu as Power of Attorney for Maryann Goebel


Share equivalents held in Company's Retirement Savings Plan as of June 30, 2025

Held jointly with spouse

Held by Monroe Partners, Ltd., a family partnership

/s/ Kathy L. Hsu as Power of Attorney for Dale M. Hudson


Surrender of shares for payment of tax withholding on release of Restricted Stock Units.

/s/ Seth G. Schuknecht, attorney-in fact


Held by Sherwood Partners, Ltd, family partnership

Common Stock

Common Stock

Stock issued from Seacoast's 2021 Incentive Plan for Board Services in 2025

Shares held in Trust

Shares held jointly with spouse

Represents shares held in the Company's Retirement Savings Plan as of June 30, 2025

Held in IRA

Granted pursuant to the Company's Amended and Restated 2013 Incentive Plan

Vests over 3 years in one-third increments each anniversary of the date of grant beginning on the first anniversary of the date of grant (the date indicated), subject to continuous employment on each vesting date and the Company's banking subsidiary meets certain capital requirements.


Common Stock

Common Stock

Common Stock

Restricted stock issued from Seacoast's 2021 Incentive Plan for services as a Director in 2025, and deferred into director's account in Seacoast's Directors Deferred Compensation Plan

/s/ Kathy L. Hsu as Power of Attorney for Alvaro J. Monserrat


Restricted stock issued from Seacoast's 2021 Incentive Plan for services as a Director in 2025, and deferred into director's account in Seacoast's Director Deferred Compensation Plan

Held jointly with spouse

/s/ Kathy L. Hsu as Power of Attorney for Thomas E. Rossin


/s/ Kathy L. Hsu as Power of Attorney for Joseph B. Shearouse, III


Common Stock

Common Stock

Held in LLC in which the reporting person is principal, as to which shares the reporting person has sole voting and dispositive power

Held jointly with spouse

Held in SEP Plan

/s/ Kathy L. Hsu as Power of Attorney for Dennis J. Arczynski


Common Stock

The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $66.67 to $67.85, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Fully vested.

Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.

Debra A. Cafaro By: /s/ Kenneth Hagan, Attorney-In-Fact


Common Stock

The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025.

The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $68.45 to $68.47, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Fully vested.

Robert F. Probst, By: /s/ Kenneth Hagan, Attorney-In-Fact


The securities are directly held by certain private investment funds and/or certain accounts (the "Applicable Accounts") managed by Eagle Point Credit Management LLC ("EPCM"). Eagle Point DIF GP I LLC ("DIF GP") serves as general partner to certain Applicable Accounts.

EPCM and DIF GP could be deemed to have an "indirect pecuniary interest" (within the meaning of Rule 16a-1(a)(2)(ii) under the Securities Exchange Act of 1934) in securities reported herein.

Each of the Reporting Persons hereby disclaims beneficial ownership of the securities described in this report pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934 and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of any of the reported securities for purposes of Section 16 or for any other purpose.

The price reported reflects the weighted average price per share. These securities were sold in multiple transactions at prices ranging from $22.24 to $22.35 per share, inclusive. Upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.


Common Stock

Common Stock

Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer.

The RSU's vest and convert into an equivalent number of shares of common stock of the issuer in equal increments on the first three anniversaries of the grant date.

The non-qualified stock options vest in equal increments on the first three anniversaries of the grant date.

/s/ Lauren Shumejda, as attorney-in-fact for Lyndon J. Smith


Stock issued from Seacoast's 2021 Incentive Plan for Board Services in 2025

Held jointly with spouse

Held individually in IRA

/s/ Kathy L. Hsu as Power of Attorney for Robert J. Lipstein


Common Stock

Common Stock

Common Stock

On July 30, 2025, 10,000 of the Reporting Person's restricted stock units were settled for an equal number of shares of the Issuer's Common Stock.

Mariposa Acquisition IX, LLC ("Mariposa IX") directly holds (i) 18,877,500 shares of Common Stock and (ii) 1,000,000 shares of Series A Preferred Stock ("Preferred Stock") convertible into shares of Common Stock for no additional consideration as set forth below. Mr. Lillie holds a limited liability company interest in Mariposa IX and, as a result, may be deemed to have a pecuniary interest in approximately (i) 1,746,169 shares of Common Stock and (ii) 92,500 shares of Common Stock issuable upon conversion of the Preferred Stock held by Mariposa IX. Mr. Lillie disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by Mariposa IX except to the extent of his pecuniary interest therein. Mr. Lillie does not have beneficial ownership over the shares of Common Stock and Preferred Stock held directly by Mariposa IX.

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

These restricted stock units vest on July 30, 2025 (the one-year anniversary of the grant date).

These restricted stock units vest on July 31, 2026 (the one-year anniversary of the grant date).

The Series A Preferred Stock is convertible at any time at the election of the holder, on a one-for-one basis, into shares of Common Stock for no additional consideration. The Series A Preferred Stock shall automatically convert into Common Stock upon the earlier of (i) immediately following the "change of control dividend date" (as defined in the Issuer's certificate of incorporation) and (ii) December 31, 2034.


Restricted stock issued from Seacoast's 2021 Incentive Plan for service as a Director in 2025, and deferred into director's account in Seacoast's Directors Deferred Compensation Plan

Held in Seacoast's Non-employee Directors Deferred Compensation Plan

Represents an unvested time-based restricted stock award granted on April 1, 2024, which shall vest over the three years in one-third increments, beginning on April 1, 2025, and on each anniversary thereafter, subject to continued employment

Held in IRA

/s/ Kathy L. Hsu as Power of Attorney for Eduardo J. Arriola


Date of Rule 10b5-1 plan adoption: 11/27/2024

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.00 to $16.01. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.


These are restricted share units granted by the Issuer, payable upon vesting in an equal number of Common Shares, which are scheduled to vest in one remaining equal annual installment on September 13, 2025.

Annual director compensation awards. These are restricted share units granted by the Issuer, payable upon vesting in an equal number of Common Shares, which are scheduled to vest in one annual installment on November 29, 2025.

Director fees granted in Common Shares of the Issuer.


These are restricted share units granted by the Issuer, payable upon vesting in an equal number of Common Shares, which are scheduled to vest in one remaining annual installment on September 13, 2025.

Annual director compensation awards. These are restricted share units granted by the Issuer, payable upon vesting in an equal number of Common Shares, which are scheduled to vest in one remaining annual installment on November 29, 2025.

These shares are held for the account of MHR Capital Partners Master Account LP, an Anguilla, British West Indies limited partnership ("Master Account"). MHR Advisors LLC, a Delaware limited liability company ("Advisors"), is the general partner of Master Account. MHRC LLC, a Delaware limited liability company ("MHRC"), is the managing member of Advisors. Mark H. Rachesky, M.D. ("Dr. Rachesky") is the managing member of MHRC. MHR Fund Management LLC ("Fund Management") has an investment management agreement with Master Account pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Master Account. MHR Holdings LLC, a Delaware limited liability company ("MHR Holdings"), is the managing member of Fund Management. (Continued to footnote 4)

Accordingly, Advisors, MHRC, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the shares held for the account of Master Account. Each of Advisors, MHRC, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein.

These shares are held for the account of MHR Capital Partners (100) LP, a Delaware limited partnership ("Capital Partners (100)"). Advisors is the general partner of Capital Partners (100). MHRC is the managing member of Advisors. Dr. Rachesky is the managing member of MHRC. Fund Management has an investment management agreement with Capital Partners (100) pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Capital Partners (100). MHR Holdings is the managing member of Fund Management. Accordingly, Advisors, MHRC, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the shares held for the account of Capital Partners (100). Each of Advisors, MHRC, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein.

These shares are held for the account of MHR Institutional Partners II LP, a Delaware limited partnership ("Institutional Partners II"). MHR Institutional Advisors II LLC, a Delaware limited liability company ("Institutional Advisors II"), is the general partner of Institutional Partners II. MHRC II LLC, a Delaware limited liability company ("MHRC II"), is the managing member of Institutional Advisors II. Dr. Rachesky is the managing member of MHRC II. Fund Management has an investment management agreement with Institutional Partners II pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Institutional Partners II. MHR Holdings is the managing member of Fund Management. (Continued to footnote 7)

Accordingly, Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the shares held for the account of Institutional Partners II. Each of Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein.

These shares are held for the account of MHR Institutional Partners IIA LP, a Delaware limited partnership ("Institutional Partners IIA"). Institutional Advisors II is the general partner of Institutional Partners IIA. MHRC II is the managing member of Institutional Advisors II. Dr. Rachesky is the managing member of MHRC II. Fund Management has an investment management agreement with Institutional Partners IIA pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Institutional Partners IIA. MHR Holdings is the managing member of Fund Management. (Continued to footnote 9)

Accordingly, Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the shares held for the account of Institutional Partners IIA. Each of Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein.

These shares are held for the account of MHR Institutional Partners III LP, a Delaware limited partnership ("Institutional Partners III"). MHR Institutional Advisors III LLC, a Delaware limited liability company ("Institutional Advisors III"), is the general partner of Institutional Partners III. Dr. Rachesky is the managing member of Institutional Advisors III. Fund Management is an affiliate of, and has an investment management agreement with, Institutional Partners III pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Institutional Partners III. MHR Holdings is the managing member of Fund Management. (Continued to footnote 11)

Accordingly, Institutional Advisors III, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the shares held for the account of Institutional Partners III. Each of Institutional Advisors III, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein.

These shares are held for the account of MHR Institutional Partners IV LP, a Delaware limited partnership ("Institutional Partners IV"). MHR Institutional Advisors IV LLC, a Delaware limited liability company ("Institutional Advisors IV") is the general partner of Institutional Partners IV. Dr. Rachesky is the managing member of Institutional Advisors IV. Fund Management is an affiliate of, and has an investment management agreement with, Institutional Partners IV pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Institutional Partners IV. MHR Holdings is the managing member of Fund Management. (Continued to footnote 13)

Accordingly, Institutional Advisors IV, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the shares held for the account of Institutional Partners IV. Each of Institutional Advisors IV, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein.

The shares reported as owned on this Form 4 do not include the shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement, by and among the Issuer, Liberty Global Ventures Limited, a limited company organized under the laws of England and Wales, Liberty Global Ltd., Bermuda exempted company limited by shares, Discovery Lightning Investments Ltd., a limited company organized under the laws of England and Wales, Warner Bros. Discovery, Inc., a Delaware corporation, Master Account, Capital Partners (100), Institutional Partners II, Institutional Partners IIA, Institutional Partners III, Institutional Partners IV and Fund Management, but as to which they have no pecuniary interest.


Common Stock

Shares acquired by inheritance.

The time-based restricted stock units were granted to the reporting person on June 26, 2025 under the Business First Bancshares, Inc. 2024 Equity Incentive Plan. The time-based restricted stock units will fully vest on June 26, 2026. Each time-based restricted stock unit is economically equivalent to one share of common stock of the issuer. Under the terms of the relevant restricted stock unit grant, the reported unvested restricted stock units are subject to forfeiture upon the occurrence of certain events.

/s/ Heather Roemer, as attorney-in-fact for Patrick E. Mockler


Date of Rule 10b5-1 plan adoption: 03/05/2025

/s/ Christopher J. Joyce, as Attorney-in-Fact, for Joseph S. Konowiecki


Pursuant to the Agreement and Plan of Merger, dated as of May 3, 2024, by and between Uniti Group Inc. ("Old Uniti") and Windstream Holdings II, LLC, as amended by Amendment No. 1 to the Agreement and Plan of Merger, dated as of July 17, 2024 (the "Merger Agreement"), the shares of Common Stock reported above were issued to the Elliott Funds (as defined below) in exchange for [10,120,963] shares of Old Uniti common stock.

This Form 4 is being filed by Elliott Investment Management L.P., a Delaware limited partnership ("EIM" or the "Reporting Person"), which serves as the investment manager of Elliott Associates, L.P., a Delaware limited partnership ("Elliott") and Elliott International, L.P., a Cayman Islands limited partnership ("Elliott International", and together with Elliott and their respective subsidiaries, the "Elliott Funds"), with respect to the securities held by the Elliott Funds. Elliott Investment Management GP LLC, a Delaware limited liability company ("EIM GP"), is the sole general partner of EIM. Paul E. Singer is the sole managing member of EIM GP. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any.

Elliott Investment Management L.P., /s/ Elliot Greenberg, Vice President


Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Offerpad Solutions Inc. (the "Issuer") Class A common stock. The RSUs vest in three equal annual installments on June 4, 2026; June 4, 2027 and June 4, 2028.

/s/ Adam Martinez, as Attorney-In- Fact for Peter H Knag


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.08 to $11.18, inclusive. The Reporting Person undertakes to provide to Ladder Capital Corp, any security holder of Ladder Capital Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.89 to $10.99, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.82 to $10.92, inclusive.

The reported securities were sold by the Reporting Person's spouse in open market transactions.

/s/ Michelle Wallach, as Attorney-in-Fact for Mark David Alexander


/s/ Adam Martinez, as Attorney-In- Fact for Brian Bair


Transaction approved by Board of Directors of Issuer and Non-Employee Directors


Common Stock

Common Stock

On July 30, 2025, 10,000 of the Reporting Person's restricted stock units were settled for an equal number of shares of the Issuer's Common Stock.

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

These restricted stock units vest on July 30, 2025 (the one-year anniversary of the grant date).

These restricted stock units vest on July 31, 2026 (the one-year anniversary of the grant date).


Common Stock

Common Stock


Common Stock

Common Stock

Common Stock

These options are fully vested and exercisable.


Common Stock

Performance Based Restricted Stock Units

Common Stock

Common Stock

Common Stock

Shares withheld for tax liability.

These restricted stock units vest 33 1/3% on the first through third anniversaries of the grant date (July 30, 2024).

Each performance based restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

Subject to the volume weighted average price ("VWAP") of the Issuer's Common Stock reaching a specified price over a ten (10) consecutive trading day period at any time during the period commencing on February 18, 2025 and ending on July 30, 2029 (the "VWAP Achievement Period"), these performance based restricted stock units shall vest on the later of (x) July 30, 2025 and (y) the calendar day following the last day of the VWAP Achievement Period.

These restricted stock units vest on the third anniversary of the grant date (April 11, 2025).

These performance based restricted stock units have a three-year performance period and to the extent earned will vest on April 11, 2028. The number of shares of Common Stock that will be earned is subject to decrease based on the result of the performance condition.


Common Stock

Common Stock

Common Stock

Common Stock

On July 30, 2025, 36,667 of the Reporting Person's restricted stock units were settled for an equal number of shares of the Issuer's Common Stock.

These performance restricted stock units have a three-year performance period and to the extent earned will vest on April 11, 2028. The number of shares of Common Stock that will be earned is subject to decrease based on the results of the performance condition.


Shares held in separate trusts for the benefit of children of the Reporting Person

The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein.


Includes  1,043 Restricted Stock Units that convert to Phillips 66 common stock on a 1-for-1 basis.

/s/ William H. Bald, as Attorney-in-Fact


Includes 1,043 Restricted Stock Units that convert to Phillips 66 common stock on a 1-for-1 basis.


Class A Common Units of Rush Street Interactive, L.P.

Class A Common Stock

On August 1, 2025, the reporting person exchanged, pursuant to the Amended and Restated Limited Partnership Agreement of Rush Street Interactive, LP ("RSI LP"), 70,000 Class A Common Stock Units ("RSI Units") for 70,000 shares of Class A Common Stock of the Issuer, together with an equivalent number of Class V Voting Stock of the Issuer held by the reporting person being canceled.

The shares of Class V Voting Stock of the Issuer provide no economic rights in the Issuer to the holder thereof. However, each holder of Class V Voting Stock will be entitled to vote as a common stockholder of the Issuer, with the number of votes equal to the number of shares of Class V Voting Stock held at the time of such vote.

Shares were sold pursuant to a 10b5-1 Plan dated September 27, 2024.

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.25 to $19.35 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Pursuant to the Amended and Restated Limited Partnership Agreement of RSI LP, beginning on June 29, 2021, the RSI Units beneficially owned by the reporting person may be exchanged, subject to certain conditions, for one share of Class A Common Stock of the Issuer. Upon such exchange, an equivalent number of shares of Class V Voting Stock then held by the reporting person will be canceled.


Class A Common Stock

Class A Common Stock

Class A Common Stock

The holder of the securities has the right, at the holder's option, at any time and from time to time, to convert shares of Class B Common Stock into Class A Common Stock on a one-for-one basis.

Reflects a gift of shares of Class B Common Stock from a trust of which Mrs. Lauren is a trustee established for the benefit of Mr. Lauren's issue to a limited liability company, which is managed by Mr. Lauren's children, including Mr. David Lauren.

These securities are held by trusts of which Mrs. Lauren is a trustee established for the benefit of Mr. Lauren's issue.

These securities are held by a trust of which Mr. Lauren is a trustee and beneficiary.

/s/ Craig L. Smith, Attorney-in-Fact for Ralph Lauren


Class A Common Stock

Class A Common Stock

Reflects a gift of shares of Class B Common Stock from a trust of which Mr. Ralph Lauren's spouse is a trustee established for the benefit of the issue of Mr. Ralph Lauren to a limited liability company of which Mr. David Lauren is a manager and in which Mr. David Lauren has an indirect pecuniary interest.  Mr. David Lauren disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

These securities are held by Lauren Consolidated LLC, a limited liability company of which Mr. David Lauren is a manager and in which Mr. David Lauren has an indirect pecuniary interest. Mr. David Lauren disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

These securities are held by Lauren Family, L.L.C., a limited liability company of which Mr. David Lauren is a manager and in which Mr. David Lauren has an indirect pecuniary interest. Mr. David Lauren disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

/s/ Craig L. Smith, Attorney-in-Fact for David Lauren


Shares were acquired under the ALGN Employee Stock Purchase Plan.


Fourth Amended and Restated Gregory E. Zimmerman Revocable Trust, dated June 2, 2015

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person on March 19, 2025.

/s/ Angela M. Whittaker, Attorney-in-Fact for Gregory E. Zimmerman


These shares of the Issuer's Common Stock were sold by the Reporting Person pursuant to a registered public offering that closed on July 25, 2025, at a price of $49.00, before deducting underwriting discounts and commissions.

Shares are directly held by RadzWest Capital LLC, of which Brian Raduenz is the Chief Executive Officer.

This amendment is being filed to correct an error in reporting the amount of common stock beneficially owned following the registered public offering on July 25, 2025. The correct amount of common stock beneficially owned after the registered public offering is 344,105, not 378,137, as was originally reported on the Form 4 filed on July 29, 2025.


Shares were sold pursuant to a 10b5-1 Plan dated August 16, 2024.

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.29 to $19.595 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Shares were sold pursuant to a 10b5-1 Plan dated March 14, 2025.

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.49 to $18.75 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These shares are held directly by Isalea Investments LP, of which the Reporting Person is the Managing Member. The Reporting Person may be deemed to have beneficial ownership of the shares held directly by Isalea Investments LP. The Reporting Person disclaims beneficial ownership of such shares, and this Form 4 shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.


Award of restricted stock under the Stryve Foods, Inc. Omnibus Incentive Plan, subject to vesting 1/3 annually.

/s/ Carolyn Short by John J. Wolfel, Attorney-in-Fact


Common Stock, par value $0.01 per share

Common Stock, par value $0.01 per share

Each restricted stock unit represents a contingent right to receive one share of LPRO common stock.

These restricted stock units vest in four equal annual installments beginning on March 15, 2026.

The stock options vest in three equal annual installments beginning on March 15, 2026.


Common Stock, par value $0.01 per share

Common Stock, par value $0.01 per share


Common Shares

Converted from Canadian exercise price of C$0.59 using an exchange rate of 1.3811.

Converted from Canadian sales price of C$2.402177 using an exchange rate of 1.3811.

/s/ Elaine Sanders as attorney-in-fact for William L. Iggiagruk Hensley


This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2025.

This transaction was executed in multiple trades at prices ranging from $72.00 to $72.99. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades at prices ranging from $73.00 to $73.963. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades at prices ranging from $74.00 to $74.88. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

/s/ Donald R. Reynolds, Attorney-in-Fact


Common Stock

Stock options vest at the rate of 1/3 per year commencing on the first anniversary of the grant date.

/s/ Jawad Chaudhry, by Ryan Blake, attorney-in-fact


Class A common stock

Non-voting common interest units of Virtu Financial LLC

Class A common stock

Shares of Class A common stock issued in settlement of vested restricted stock units ("RSUs") granted under the Issuer's Second Amended and Restated 2015 Management Incentive Plan.

Shares of Class A common stock withheld for tax by the Issuer in relation to the settlement of vested RSUs in accordance with the Issuer's Second Amended and Restated 2015 Management Incentive Plan.

Each RSU is granted under the Issuer's Second Amended and Restated 2015 Management Incentive Plan and represents a contingent right to receive one share of Class A common stock of the Issuer.

The RSUs vested August 1, 2025.

Pursuant to the terms of the Exchange Agreement, effective as of April 15, 2015, by and among the Issuer, Virtu Financial LLC and the equityholders of Virtu Financial LLC (the "Exchange Agreement"), Virtu Financial Units, together with a corresponding number of shares of Class C Common Stock, may be exchanged for shares of Class A Common Stock, which have one vote per share and economic rights (including rights to dividends and distributions upon liquidation), on a one-for-one basis at the discretion of the holder. The exchange rights under the Exchange Agreement do not expire.

By Virtu Employee Holdco LLC, a holding vehicle through which employees and directors of the Issuer hold vested and unvested Virtu Financial Units and shares of Class C Common Stock. The reporting person disclaims beneficial ownership in such Virtu Financial Units and shares held by Virtu Employee Holdco LLC except to the extent of his pecuniary interest therein.


Common Stock

The Reporting Person has irrevocably elected to satisfy all withholding tax due upon the delivery of shares by authorizing Etsy, Inc. to withhold a sufficient amount of shares to satisfy such tax obligation.

Units correspond 1-for-1 with common stock.

Represents the number of shares earned under a PSU award based on the satisfaction of certain performance criteria of the award. Each PSU represents the contingent right to receive one share of common stock of the Issuer. Such shares were not reportable under Section 16 until the performance conditions were certified by the Issuer's Compensation Committee as achieved (which occurred on July 30, 2025). The earned shares will vest in equal installments on each of October 1, 2025; April 1, 2026; and April 1, 2027; subject to the Reporting Person remaining continuously employed through each vesting date. The earned shares reported on this form represent shares earned with respect to 75% of the target shares subject to the PSU award. The remaining 25% of the target shares subject to the PSU award may be earned upon the satisfaction of additional performance vesting criteria through the end of the applicable performance period.


Common Stock

These shares are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees.

These deferred stock units are granted under the Issuer's Omnibus Equity Incentive Plan and represent partial payment of the director's retainer and director fees. Each deferred stock unit represents the right to receive one share of common stock of the Issuer.

/s/ Mark D. Denny, as attorney-in-fact for Edmund P. Segner, III


Common Stock

/s/ Mark D Denny, as attorney-in-fact for Jarvis V. Hollingsworth


Common Stock

/s/ Mark D. Denny as attorney-in-fact for Frances Powell Hawes


Common Stock

/s/ Mark D. Denny as attorney-in-fact for Craig M. Jarchow


Common Stock

/s/ Mark D. Denny as attorney-in-fact for Shihab A. Kuran


Common Stock

/s/ Mark D. Denny as attorney-in-fact for William E. Albrecht


Common Stock

/s/ Mark D. Denny as attorney-in-fact for John Driver


Common Stock

/s/ Mark D. Denny as attorney-in-fact for Lori A. Lancaster


Common Stock

/s/ Michael A. Shriner, by Edward Hogan, attorney-in-fact


These reported securities represent deferred stock units ("DSUs") granted under the Issuer's 2024 Incentive Compensation Plan. The shares of common stock underlying such DSUs shall be issued upon the Reporting Person's separation from service with the Issuer.

The reported securities include (a) 63,657 DSUs granted under the Issuer's 2012 Incentive Compensation Plan and (b) 11,952 DSUs granted under the Issuer's 2024 Incentive Compensation Plan. The shares of common stock underlying such DSUs shall be issued upon the Reporting Person's separation from service with the Issuer.

These shares represent shares of common stock of the Issuer held by the Reporting Person, of which 5,000 are held jointly by the Reporting Person and his spouse.

/s/ Brett W. Johnston, as Attorney-in-Fact


The reported securities include (a) 18,027 DSUs granted under the Issuer's 2012 Incentive Compensation Plan and (b) 11,910 DSUs granted under the Issuer's 2024 Incentive Compensation Plan. The shares of common stock underlying such DSUs shall be issued upon the Reporting Person's separation from service with the Issuer.

These shares represent shares of common stock of the Issuer held by the Reporting Person.


Common Stock

Common Stock


Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2026 Annual Meeting of Stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2025 Annual Meeting of Stockholders).


Restricted stock purchase under employee stock purchase plan.


Adoption date of referenced 10b5-1(c) plan is: 12/05/2024


Issuance of shares by the Company in satisfaction of fees.


Represents Class A common stock of the Issuer acquired upon settlement of a restricted stock unit award previously granted to the Reporting Person.

The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions ranging from $177.65 to $178.39, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.


Class A Common Stock

Partnershp Units of PJT Partners Holdings LP

Class A Common Stock

On May 29, 2025, the Reporting Person submitted an Election to Exchange 15,000 Partnership Units of PJT Partners Holdings LP ("Partnership Units"), with such exchange to be settled for either cash or Class A Common Stock as determined by the Issuer's Board of Directors.

Subject to the terms of the Issuer's Exchange Agreement, on a quarterly basis, Partnership Units may be exchanged for cash, or at the election of the Issuer, shares of Class A Common Stock of the Issuer on a one-for-one basis.

Effective July 31, 2025, the Reporting Person's Partnership Units were exchanged for cash.

Includes Partnership Units that were acquired upon the occurrence of specified vesting events or grants and previously reported as either Performance LTIP Units or LTIP Units of PJT Partners Holdings LP.  Of the 693,736 Partnership Units reported, 33,490 remain subject to previously disclosed time-based vesting conditions on various dates through March 1, 2029.


Class A Common Stock

In an SEC Form 8-K filed by the Issuer on June 3, 2024, the Issuer previously disclosed that the Reporting Person intended to elect to exchange up to 90,000 Partnership Units of PJT Partners Holdings LP ("Partnership Units") in future quarterly exchange windows, including each of the Issuer's current quarterly exchange window and next quarterly exchange window.  On May 22, 2025, the Reporting Person submitted an Election to Exchange 90,000 Partnership Units, with such exchange to be settled for either cash or Class A Common Stock, as determined by the Issuer's Board of Directors.

Includes Partnership Units that were acquired upon the occurrence of specified vesting events or grants and previously reported as Performance LTIP Units of PJT Partners Holdings LP.  Of the 5,550,000 Partnership Units reported, 400,000 remain subject to previously disclosed time-based vesting conditions through March 1, 2027.


The shares were acquired from rights offering.